About ProBioGen AG
ProBioGen AG is a Healthcare company based in Berlin (Germany) founded in 1994, and was acquired by Minipharm Pharmaceuticals. in June 2010. It operates as a contract development and manufacturing organization focussed on therapeutic proteinsantibodies, viral vaccines and biosimilars. ProBioGen AG has completed 1 acquisition, including Minipharm Pharmaceuticals. ProBioGen AG offers products and services including Cell Line Development, GMP Manufacturing, Process Development, and Analytics and Bioassays. Its focus areas include Biopharma Outsourcing, CDMO, Biologics and Mammalian Cell Line. Its competitors include Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and MabPlex and 4 more; 5 of its 9 listed competitors have raised funding.
Company details
ProBioGen AG was founded in 1994 in Berlin, Germany, as a contract development and manufacturing organization in the biopharmaceutical sector. Cell line engineering, upstream and downstream process development, and GMP manufacturing are provided for therapeutic proteins, antibodies, viral vaccines, and biosimilars. Services encompass customized packages from initial cell line development through to full production programs, supported by physicochemical analyses and activity assays.
- Headquarters Berlin, Germany
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website probiogen.de
- Social LinkedIn YouTube
- Acquired by Minipharm Pharmaceuticals. (Jun 2010)
- Legal Name Probiogen Ag
- InvestorsMerus
& 1 more
- Investments & Acquisitions
- Acquired byMinipharm Pharmaceuticals.
(Jun 2010)
Products & Services of ProBioGen AG
ProBioGen AG offers a comprehensive portfolio of products and services, including Cell Line Development, GMP Manufacturing, Process Development, and Analytics and Bioassays.
Develops cell lines for biopharmaceutical production and optimization.
Produces biopharmaceuticals under GMP standards for clinical use.
Designs and optimizes processes for biopharmaceutical and viral production.
Performs testing and analysis for biopharmaceutical quality assurance.
Apps and channels of ProBioGen AG
its YouTube channel ProBioGen AG has 11 subscribers and 5 videos.
Videos from ProBioGen AG
The most watched videos on ProBioGen AG's YouTube channel, ProBioGen AG (11 subscribers). Click a video to play it here.
More on ProBioGen AG.
Funding Insights of ProBioGen AG
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of ProBioGen AG with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2018 | – | Private Equity Round | – | – |
2 investors in total: 2 institutional.
Investors in ProBioGen AG
ProBioGen AG has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Merus and Minipharm Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Antibody-based drugs for cancer treatment are developed using bispecific engineering. | 2003 | merus.nl | Utrecht, Netherlands | |
Pharma and biopharma products are manufactured by Minipharm. | 1958 | minapharm.com | Masr Al Jadidah, Egypt |
Investor details for ProBioGen AG
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ProBioGen AG
33 people are tracked at ProBioGen AG (13 in leadership, 20 in team).
| Name | Role | Group |
|---|---|---|
Ingo Jordan | Vice President Vaccine Strategies | Leadership |
Josefine Pursche | People Business Partner | Leadership |
Julian Collins | Senior Vice President People & Organizational Development | Leadership |
Kashish Manchanda | Director Of Business Development | Leadership |
Claudia Conert | Head Of DSP Development II | Leadership |
Dr. Sascha Ramm | Head Of DSP Development I | Leadership |
Lukas Rositzka | Head Of USP Production | Leadership |
Tanja Arnouk | Head Of Viral Vector Processing Development & Production | Leadership |
Holger Bernhardt | Head Buffer Media Production | Leadership |
Michiel Stork | Vice President Business Development | Leadership |
Andrea Naujoks | Head Of Microbiology | Leadership |
Andrea Hauptmann | CFO | Leadership |
Katharina Vogdt | Head Of Vector Processes | Leadership |
Anika Bauer | Associate Scientist | Team |
Doreen Uebe | Associate Scientist | Team |
Lina Hanisch | Biotechnologist Vaccine Strategies | Team |
Matthias Kaup | Protein Analytics Specialist | Team |
Anastasia Piltsi | Data Scientist | Team |
Christian Auerbach | Senior Process Engineer | Team |
Dirk Matthias | It-techniker | Team |
13 more people are available in the full profile.
Complete people profiles for ProBioGen AG
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ProBioGen AG
ProBioGen AG has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Minipharm Pharmaceuticals..
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Pharma and biopharma products are manufactured by Minipharm. | minapharm.com | Masr Al Jadidah, Egypt | 1958 | Jun 2010 | $37M |
Complete acquisition details for ProBioGen AG
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of ProBioGen AG
4 dated milestones of ProBioGen AG across 24 years, from founding to its latest funding, stage changes and deals.
- Founded ProBioGen AG is founded.
- Exit Acquired by Minipharm Pharmaceuticals..
- Acquisition Acquires Minipharm Pharmaceuticals..
- Funding First funding round.
Competitors of ProBioGen AG
ProBioGen AG has 9 listed competitors in our database, 5 of them funded. They include Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and MabPlex, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bionovascientific.com | 2013 | Fremont, United States | $22M | 72 | Mammalian cell culture biologics are developed through contract research services. | |
| justbiotherapeutics.com | 2014 | Seattle, United States | $123.51M | 79 | Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs | |
| jhlbiotech.com | 2012 | Hsinchu, Taiwan | $186.6M | – | Contract manufacturing solutions for biologics are provided to Asian companies. | |
| avidbio.com | 2002 | Orange, United States | – | 501 | Drug substance development, analytical, and compliance services are provided. | |
| mabplexinc.com | 2013 | Yantai, China | $130M | – | Biologics development and GMP manufacturing services are offered. | |
| rentschler-biopharma.com | 1927 | Laupheim, Germany | – | 861 | Full-service CDMO for biopharmaceuticals | |
| agcbio.com | 2018 | Bothell, United States | – | 1,290 | Provides contract development and manufacturing for biopharmaceuticals worldwide. | |
| therapurebio.com | 2008 | Mississauga, Canada | – | – | Complex biologics are developed and manufactured by Therapure Biopharma. | |
| autekbio.com | 2006 | Santa Clara, United States | $101.03M | – | Biopharma CDMO specializing in the production of therapeutic proteins and antibodies from mammalian cell culture. |
Detailed competitors of ProBioGen AG
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ProBioGen AG
The website of ProBioGen AG (probiogen.de) receives about 9.2K visits a month and ranks #3,075,741 among all websites worldwide, #4,062 in Biotechnology and Pharmaceuticals.
- Monthly visits9.2K
▲ 31.7% vs previous month
- Unique visitors3.1K
per month
- Global rank#3,075,741
among all websites
- Category rank#4,062
Health · Biotechnology and Pharmaceuticals
- Bounce rate58%
- Pages per visit1.5
- Average visit54 sec
- DevicesDesktop 42% · Mobile 58%
Websites whose visitors overlap most with ProBioGen AG. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| rd-biotech.com | 100% | 1.7K | #11,064,917 | View details | |
| covance.com | 100% | 20.2K | #688,229 | View details | |
| bioreliance.com | 100% | 2.1K | #7,984,772 | View details | |
| formatech.com | 100% | – | – | View details | |
fapon.com | fapon.com | 100% | – | – | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for ProBioGen AG
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
10 companies that operate in the same segment as ProBioGen AG (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Probiogen Ag
Complete news archive for ProBioGen AG
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ProBioGen AG
ProBioGen AG was founded in 1994 and raised its 1st funding round 24 years after it was founded.
ProBioGen AG is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
ProBioGen AG was founded in 1994 in Berlin, Germany, as a contract development and manufacturing organization in the biopharmaceutical sector. Cell line engineering, upstream and downstream process development, and GMP manufacturing are provided for therapeutic proteins, antibodies, viral vaccines, and biosimilars. Services encompass customized packages from initial cell line development through to full production programs, supported by physicochemical analyses and activity assays.
ProBioGen AG's top competitors include Avid Bioservices, Bionova Scientific and Rentschler Biopharma.
ProBioGen AG offers Cell Line Development, GMP Manufacturing, Process Development, and Analytics and Bioassays.
ProBioGen AG has made 1 acquisition, including Minipharm Pharmaceuticals.
ProBioGen AG has 2 investors. Key investors include Merus, and Minipharm Pharmaceuticals.
ProBioGen AG operates through Probiogen Ag.
Yes. ProBioGen AG was acquired by Minipharm Pharmaceuticals. in June 2010.